Vnitr Lek 2023, 69(3):E24-E27 | DOI: 10.36290/vnl.2023.038

Whats new in ESC Guidelines for the management of valvular heart disease?

Marian Branny
Kardiovaskulární oddělení a Interní a kardiologické kliniky Fakultní nemocnice Ostrava a Lékařská fakulta Ostravské univerzity

The article summarize the most important changes regarding the management of valvular heart disease, which have been made in the ESC Guidelines 2021. Based on the randomized clinical study data, which were recently published, the most frequent changes were done in terms of the choice of mode of intervention in the aortic and mitral valves as well as in the management of the antithrombotic therapy.

Keywords: aortic regurgitation, aortic stenosis, guidelines, mitral regurgitation, mitral stenosis, percutaneous valve intervention, prosthetic heart valves, tricuspid regurgitation, tricuspid stenosis, valve disease, valve surgery, valvular heart disease.

Accepted: April 27, 2023; Published: May 16, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Branny M. Whats new in ESC Guidelines for the management of valvular heart disease? Vnitr Lek. 2023;69(3):E24-27. doi: 10.36290/vnl.2023.038.
Download citation

References

  1. Vahanian A, Bayersdorf F, Praz F. 2021 ESC/EACTS Guidelines for the management of valvular heart disease, European Heart Journal. (2021)00,1-7. Go to original source... Go to PubMed...
  2. Stone GW, Lindenfeld J, Abraham WT, COAPT Investigators. Transcatheter mitral‑valve repair in patients with heart failure. N Engl J Med. 2018;379:23072318. Go to original source... Go to PubMed...
  3. Kang DH, Park SJ, Lee SA. Early surgery or conservative care for asymptomatic aortic stenosis. N Engl J Med. 2020;382:111-119. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.